Back to mobile site

More on EWTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-55.9% Growth)
- Ratings (7.9 Score)

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Edgewise Therapeutics Inc. (NQ:EWTX)
Delayed: 43.52 -0.9 (2.03%)
Prev. Close $44.42  
Open$44.00 
52 Wk High$ 
52 Wk Low$ 
Day High$44.20 
Day Low$42.46 
P/E N/A  
EPS$ 
Volume1,477,481 

Friends, Peers and Foes (?): ACAD, BCRX, CATX, CDTX, CRBP (more...)

Aug 6, 2026 10:20 AM Form SCHEDULE 13G Edgewise Therapeutics, Filed by: FMR LLC
Aug 6, 2026 08:09 AM Edgewise Therapeutics, Inc. (EWTX) Misses Q2 EPS by 6c
Aug 6, 2026 08:06 AM Form 10-Q Edgewise Therapeutics, For: Jun 30
Aug 6, 2026 08:06 AM Form 8-K Edgewise Therapeutics, For: Aug 06
Aug 6, 2026 08:00 AM Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
Jul 17, 2026 04:25 PM Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: ROOT JONATHAN D
Jul 16, 2026 08:01 AM Form 8-K/A Edgewise Therapeutics, For: Jul 10
Jul 13, 2026 08:37 AM Form 8-K Edgewise Therapeutics, For: Jul 10
Jul 13, 2026 08:30 AM Edgewise sells muscular dystrophy drug to Servier for up to $2.65B
Jul 13, 2026 08:30 AM Servier buys Edgewise muscular dystrophy unit for up to $2.65B
View All Articles

Entities mentioned with EWTX

View All Entities